Patents by Inventor Mildred Goldman

Mildred Goldman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICROSAMPLING DETECTION IN DIABETES
    Publication number: 20210239717
    Abstract: The present disclosure relates to methods of detecting various analytes, including glycated hemoglobin (HbA1c) and total hemoglobin (THb), in a biological sample obtained with a microsampling device.
    Type: Application
    Filed: August 21, 2019
    Publication date: August 5, 2021
    Applicant: Quest Diagnostics Investments LLC
    Inventors: Nigel Clarke, Mildred Goldman, Jueun Kim, Jane Yang
  • MASS SPECTROMETRY ASSAY FOR ESTROGENIC COMPOUNDS
    Publication number: 20210063418
    Abstract: Methods are provided for detecting the amount of one or more HRT panel analytes (i.e., estrone (E1), estrone sulfate (E1s), 17?-estradiol (E2a), 17?-estradiol (E2b), estradiol sulfate (E2s), estriol (E3), equilin (EQ), 17?-dihydroequilin (EQa), 17?-dihydroequilin (EQb), Equilenin (EN), 17?-dihydroequilenin (ENa), 17?-dihydroequilenin (ENb), and ?8,9-dehydroestrone (dE1)) in a sample by mass spectrometry. The methods generally involve ionizing one or more HRT panel analytes in a sample and quantifying the generated ions to determine the amount of one or more HRT panel analytes in the sample. In methods where amounts of multiple HRT panel analytes are detected, the amounts of multiple analytes are detected in the same sample injection.
    Type: Application
    Filed: November 12, 2020
    Publication date: March 4, 2021
    Inventors: Mildred GOLDMAN, Nigel J. CLARKE
  • Mass spectrometry assay for estrogenic compounds during hormone replacement therapy
    Patent number: 10837971
    Abstract: Methods are provided for detecting the amount of one or more HRT panel analytes (i.e., estrone (E1), estrone sulfate (E1s), 17?-estradiol (E2a), 17?-estradiol (E2b), estradiol sulfate (E2s), estriol (E3), equilin (EQ), 17?-dihydroequilin (EQa), 17?-dihydroequilin (EQb), Equilenin (EN), 17?-dihydroequilenin (ENa), 17?-dihydroequilenin (ENb), and ?8,9-dehydroestrone (dE1)) in a sample by mass spectrometry. The methods generally involve ionizing one or more HRT panel analytes in a sample and quantifying the generated ions to determine the amount of one or more HRT panel analytes in the sample. In methods where amounts of multiple HRT panel analytes are detected, the amounts of multiple analytes are detected in the same sample injection.
    Type: Grant
    Filed: August 30, 2016
    Date of Patent: November 17, 2020
    Assignee: Quest Diagnostics Investments Incorporated
    Inventors: Mildred Goldman, Nigel Clarke
  • METHODS FOR MASS SPECTROMETRIC QUANTITATION OF ANALYTES EXTRACTED FROM A MICROSAMPLING DEVICE
    Publication number: 20160349221
    Abstract: Mass spectrometric methods are described for determining the amount of analyte in a sample collected by a microsampling device. Provided herein are methods directed to quantitating the amount of an analyte in a sample by extracting an analyte from a sample collected by a microsampling device, purifying the sample by liquid chromatography, ionizing the analyte to generate one or more ions detectable by mass spectrometry; and determining the amount of the one or more ions by mass spectrometry. The amount of analyte in the sample is related to the amount of analyte in the patient.
    Type: Application
    Filed: May 27, 2016
    Publication date: December 1, 2016
    Applicant: Quest Diagnostics Investments LLC
    Inventors: Scott Goldman, Mildred Goldman, Leslie Edinboro, Diana Tran, Julia Addiss, Darren Weber, Porus Mistry, Nigel Clarke